7 employees
NeuroPsyCAD provides clinicians with patient-personalized reports for early and accurate diagnoses of neuropsychiatric disorders.
2017
$59K
from 1 investors over 1 rounds
NeuroPsyCAD raised $59K on December 1, 2017
Investors: Executive Agency for Small and Medium-sized Enterprises (EASME)